Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 715 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Study Finds Light Therapy Helps Radiation-Related Skin Damage Heal 50% Faster February 3, 2022 Lack of Evidence for the Use of Telemedicine in the Prevention... September 13, 2021 Jonas Brothers Visit Fan In Hospital Who Missed Their Concert Due... September 9, 2019 FDA Approves First Adenoviral Vector-Based Gene Therapy for High-Risk Bacillus Calmette-Guérin... January 19, 2023 Load more HOT NEWS 3 Things to Reduce Stress During Cancer Treatment: A Patient’s Perspective Pembrolizumab Plus Weekly Paclitaxel, With Or Without Bevacizumab, Improves OS in... Women in science: Cancer research pioneers – part 2 10 Ways to Provide Support During Breast Cancer Awareness Month
